8-KOther EventsExhibits & Filings

AbbVie Inc. 8-K Report, Corporate Update (Dec 20, 2019)

Filed December 20, 2019For Securities:ABBV

Summary

AbbVie Inc. (ABBV) filed an 8-K on December 20, 2019, primarily to disclose a press release dated December 20, 2019. While the 8-K itself does not contain extensive operational or financial details, it serves as a formal notification of information disseminated by the company via press release. Investors should refer to the press release (Exhibit 99.1) for the specific details of the announcement, which is the material event being reported. The core purpose of this filing is to make the press release publicly available through the SEC's EDGAR system. Therefore, the key takeaways for investors will be found within the content of that press release. Without access to the press release's content, this 8-K filing is largely procedural, indicating that AbbVie has communicated new information to the market. Investors are advised to seek out and review Exhibit 99.1 for any significant developments.

Key Highlights

  • 1AbbVie Inc. filed a Form 8-K on December 20, 2019.
  • 2The filing's primary purpose is to announce information contained in a press release.
  • 3The press release is dated December 20, 2019, and is included as Exhibit 99.1.
  • 4Investors should consult Exhibit 99.1 for the specific details of the announcement.
  • 5The 8-K serves as the formal SEC reporting mechanism for the press release content.
  • 6Inline XBRL data for the report's cover page is also included as Exhibit 104.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report and make publicly available a press release issued by AbbVie Inc. on December 20, 2019. The content of this press release is the material information being disclosed.

The specific details of the announcement are contained within the press release dated December 20, 2019, which is included as Exhibit 99.1 to this 8-K filing. Investors should review this exhibit for comprehensive information.

This particular 8-K filing (Item 9.01) is focused on exhibits, specifically the press release and XBRL data. It does not present new financial statements or detailed financial performance data itself. Such information would typically be found in other sections of an 8-K or in different SEC filings like 10-Q or 10-K.

Exhibit 104 refers to the cover page of the Current Report on Form 8-K formatted in Inline XBRL. This is a standardized format for regulatory filings that makes data more easily extractable and analyzable.